KMG Psychiatry is an integrative outpatient psychiatric practice operating under KAB Medical Group Inc, serving patients across San Diego, Chula Vista, and Vista, California. Founded in October 2016, the practice provides mental health care through psychiatric evaluations, medication management, psychotherapy, counseling, forensic mental health services, sleep medicine services, and interventional treatment options. Its care includes support for depression, post-traumatic stress disorder, anxiety disorders, bipolar disorder, autism spectrum disorders, and other psychiatric or neurodevelopmental conditions. The practice serves adults, adolescents, and children based on diagnosis and clinical need. KMG Psychiatry was formed to respond to common challenges in outpatient psychiatric care, including long appointment delays, fragmented services, and limited access to newer evidence-based treatments. From its beginning, the practice has held that effective mental health care should be organized around the individual rather than a fixed treatment model. Each patient begins with a comprehensive mental health evaluation, which allows providers to consider the patient's diagnosis, treatment history, current symptoms, and response to prior care before developing a treatment plan. The practice’s clinical philosophy is based on the understanding that psychiatric disorders often require more than one type of support. Medication management may be an important part of treatment for many patients, especially those with complex symptoms or co-occurring conditions. At the same time, psychotherapy and counseling can help address trauma responses, behavior patterns, emotional distress, and coping strategies. KMG Psychiatry uses these services together when appropriate, adjusting care over time as patients make progress or as their clinical needs change. A significant part of the practice’s work focuses on depression and PTSD, particularly among military personnel, veterans, and their families. KMG Psychiatry recognizes that military-connected patients may face pressures related to trauma exposure, service demands, family responsibilities, and transitions in daily life. Treatment plans for these patients may include therapy, medication management, and interventional care when clinically indicated. The practice also places importance on serving underserved communities, reflecting its broader goal of making outpatient psychiatric care more available to people who may face barriers to treatment. Transcranial magnetic stimulation, or TMS, is one of the defining treatment services offered by KMG Psychiatry. The practice uses NeuroStar Advanced Therapy, an FDA-cleared technology approved for the treatment of major depressive disorder since 2008. TMS uses targeted magnetic pulses, similar in strength to those used in MRI machines, to stimulate underactive nerve cells in brain regions associated with mood regulation. This treatment may be considered for patients with depression who need an evidence-based option beyond traditional antidepressant medication. At KMG Psychiatry, TMS is delivered in an office setting, with the patient awake and seated comfortably. The process begins with an initial mapping session to identify the proper treatment area. During treatment, a small, curved magnetic coil is placed gently against the patient’s head, where it delivers magnetic pulses to the targeted brain region. Patients may hear a clicking sound and feel a light tapping sensation during the session. Treatments generally last 19 to 37 minutes and are usually provided 5 days per week for 4 to 6 weeks. The practice describes TMS as a noninvasive treatment with a favorable safety profile. It does not require anesthesia, surgery, or implanted devices, and patients can return to normal daily activities after each session. Possible side effects include headaches, lightheadedness, scalp discomfort, facial muscle spasms, and tingling sensations in the face. Rare risks include seizures, hearing issues without proper ear protection, and manic symptoms in patients with bipolar disorder. KMG Psychiatry presents TMS as one part of a broader care plan, not as a replacement for all other psychiatric services. KMG Psychiatry has received recognition for its work in the region and its experience with NeuroStar TMS treatment. The practice was voted Best in San Diego by SD Magazine in both 2024 and 2025. It has also achieved Diamond Circle Provider status from NeuroStar for administering more than 2,400 NeuroStar treatments in a single year. With multiple office locations and appointments offered within one week of booking for new and returning patients, the practice continues to provide outpatient mental health care with attention to access, consistency, and individualized treatment planning.